Literature DB >> 18565874

Imatinib as a possible cause of severe rhabdomyolysis.

Nicolas Penel, Jean-Yves Blay, Antoine Adenis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18565874     DOI： 10.1056/NEJMc0708896

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors.

Authors:  Antoine Adenis; Olivier Bouché; François Bertucci; Elsa Kalbacher; Charles Fournier; Philippe Cassier; Olivier Collard; Jacques-Olivier Bay; Antoine Italiano; Christine Chevreau; Stéphanie Clisant; Andrew Kramar; Jean-Yves Blay; Nicolas Penel
Journal:  Med Oncol       Date:  2012-03-24       Impact factor: 3.064

2.  Cabozantinib-induced serum creatine kinase elevation and musculoskeletal complaints.

Authors:  Sarah E Stump; Young E Whang; Daniel J Crona
Journal:  Invest New Drugs       Date:  2018-06-28       Impact factor: 3.850

Review 3.  Neurological adverse effects caused by cytotoxic and targeted therapies.

Authors:  David Schiff; Patrick Y Wen; Martin J van den Bent
Journal:  Nat Rev Clin Oncol       Date:  2009-08-25       Impact factor: 66.675

4.  Rhabdomyolysis associated with fenofibrate monotherapy in a patient with chronic myelogenous leukemia.

Authors:  Kazuya Kato; Astushi Nagase; Minoru Matsuda; Yurina Kato; Kazuhiko Onodera; Takako Kawakami; Mineko Higuchi; Yoshiaki Iwasaki; Masahiko Taniguchi; Hiroyuki Furukawa
Journal:  Case Rep Gastroenterol       Date:  2011-08-27

5.  Inclusion body myositis in a patient with chronic myeloid leukemia treated with dasatinib: a case report.

Authors:  Naif I AlJohani; Simon Carette; Jeffrey H Lipton
Journal:  J Med Case Rep       Date:  2015-09-16

6.  An unexpected and devastating adverse event of dasatinib: Rhabdomyolysis.

Authors:  Burak Uz; Ilhan Dolasik
Journal:  Leuk Res Rep       Date:  2015-12-03

Review 7.  Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review.

Authors:  Kenar D Jhaveri; Rimda Wanchoo; Vipulbhai Sakhiya; Daniel W Ross; Steven Fishbane
Journal:  Kidney Int Rep       Date:  2016-09-21

8.  A case of rhabdomyolysis related to sorafenib treatment for advanced hepatocellular carcinoma.

Authors:  Kunihiro Tsuji; Kenichi Takemura; Keisuke Minami; Ryota Teramoto; Keisuke Nakashima; Shinya Yamada; Hisashi Doyama; Hisanori Oiwake; Kenkou Hasatani
Journal:  Clin J Gastroenterol       Date:  2013-05-17

9.  Rhabdomyolysis due to Trimethoprim-Sulfamethoxazole Administration following a Hematopoietic Stem Cell Transplant.

Authors:  Alexander Augustyn; Mona Lisa Alattar; Harris Naina
Journal:  Case Rep Oncol Med       Date:  2015-10-18

Review 10.  Drug induced rhabdomyolysis.

Authors:  Martin Hohenegger
Journal:  Curr Opin Pharmacol       Date:  2012-05-05       Impact factor: 5.547
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.